Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,301
datasets available to search
ShareScore release 0.9.0
Dataset results
1,301 results for “retrospective study”
Association of fat-to-muscle ratio with non-alcoholic fatty liver disease: a single-centre retrospective study
<p><strong>Objectives</strong>: Sarcopenia is a known risk factor for non-alcoholic fatty liver disease (NAFLD). Studies evaluating the association between the fat-to-muscle ratio (FMR) and NAFLD are limited. Therefore, the aim of our study was to investigate the association between FMR and NAFLD.</p> <p><strong>Design:</strong> A retrospective study was conducted on the individuals who underwent health examination in Wuhan Union Hospital between January 2020 and November 2021. Clinical data were collected from electronic medical records.</p> <p><strong>Setting:</strong> Our study was conducted in a hospital in China.</p> <p><strong>Participants:</strong> A total of 1,592 participants aged ≥40 years who underwent body composition analysis and liver ultrasonography were retrospectively reviewed.</p> <p><strong>Primary outcome measures:</strong> Liver ultrasonography was used to assess liver steatosis, and the Fibrosis-4 Index (FIB-4) was used to calculate the risk scores for liver fibrosis. The 10-year atherosclerotic cardiovascular disease (ASCVD) risk prediction model was used to calculate ASCVD risk scores.</p> <p><strong>Results:</strong> The FMR was significantly higher in individuals with NAFLD than in those without NAFLD (P<0.001). The prevalence of NAFLD gradually increased from FMR tertile 1 (reference) to tertile 2 (OR=1.49, 95% CI: 1.13–1.97) and tertile 3 (OR=2.85, 95% CI: 2.08–3.90). In addition, patients with NAFLD in FMR tertile 3 had a significantly higher risk of liver fibrosis (OR=4.48, 95% CI: 2.12–9.50) and ASCVD (OR=4.63, 95% CI: 2.62–8.19) than those in FMR tertile 1 after adjustment for multiple confounders.</p> <p><strong>Conclusion:</strong> In this study, we found a significant association between FMR and NAFLD. A higher FMR indicates a higher risk of NAFLD in the study population and a higher risk of liver fibrosis and ASCVD in NAFLD patients.</p>
A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib
ClinicalTrials.gov study NCT05599334. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Development and Validation of a Deep Learning-Based Survival Prediction Model for Pediatric Glioma Patients: A Retrospective Study Using the SEER Database and Chinese Data
ClinicalTrials.gov study NCT06199388. IPD Sharing: NO. Countries: 1. Publications: 2.
Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy
ClinicalTrials.gov study NCT04309617. IPD Sharing: NO. Countries: 1. Publications: 1.
Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis
ClinicalTrials.gov study NCT07373951. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)
ClinicalTrials.gov study NCT01411696. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Retrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received Alpelisib
ClinicalTrials.gov study NCT04285723. IPD Sharing: NO. Countries: 5. Publications: 3.
Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism
ClinicalTrials.gov study NCT01004939. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies
ClinicalTrials.gov study NCT01977846. IPD Sharing: Not stated. Countries: 4. Publications: 9.
A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.
ClinicalTrials.gov study NCT02757950. IPD Sharing: NO. Countries: 1. Publications: 1.
A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema
ClinicalTrials.gov study NCT01918371. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of the Novel Implant Disease Risk Assessment : a Retrospective Study (IDRA)
ClinicalTrials.gov study NCT04888572. IPD Sharing: NO. Countries: 1. Publications: 2.
Multidisciplinary Prehabilitation to Improve Frailty and Functional Capacity in High-risk Elective Surgical Patients: a Retrospective Pilot Study
ClinicalTrials.gov study NCT05668221. IPD Sharing: NO. Countries: 1. Publications: 1.
Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)
ClinicalTrials.gov study NCT02443571. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)
ClinicalTrials.gov study NCT01419028. IPD Sharing: Not stated. Countries: 7. Publications: 1.
A Five-Year Metal-on-Metal Retrospective Clinical Study
ClinicalTrials.gov study NCT01481896. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Does Orthopedic Surgery Improve Gait Efficiency in Children With Cerebral Palsy? A Retrospective Study
ClinicalTrials.gov study NCT06624280. IPD Sharing: NO. Countries: 1. Publications: 19.
Our Anesthesia Experiences in Hepatopancreatobiliary Surgery Practices: a Retrospective Study
ClinicalTrials.gov study NCT06002776. IPD Sharing: NO. Countries: 1. Publications: 3.
Retrospective, Observational Chart Review Study Conducted in Poland to Document the Management and Clinical Outcome of CUVITRU and HYQVIA in Pediatric Participants (< 18 Years) With Primary Immunodefi
ClinicalTrials.gov study NCT04636502. IPD Sharing: YES. Countries: 1. Publications: 2.
Clinical Retrospective Study Analysis of Postoperative Complications Following Hepatectomy
ClinicalTrials.gov study NCT06532214. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.